Bristol-Myers Squibb (BMY)
$39.66
0.20 (0.51%)
BMY Stock Quote Delayed 30 Minutes
7 Cutting-Edge Biotech Stocks for Tomorrow
Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
88.13B
PE Ratio
-12.79
EPS
-3.1
Volume (Avg. Vol.)
12.82M
Day's Range
$39.35 - $39.75
52-Week Range
$39.35 - $65.38
Dividend & Yield
$2.28 (5.75%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
Bristol-Myers Squibb Earnings: BMY Stock Jumps 2% on Q2 Beats
Bristol-Myers Squibb earnings on Thursday have BMY stock rising higher after the company beat EPS and revenue estimates from Wall Street.
Bristol-Myers Squibb Is a Dirt-Cheap Buy Before Earnings
Thanks to its Celgene acquisition, Bristol-Myers Squibb looks attractive ahead of earnings. Here's why you should buy BMY stock.
Bristol-Myers Squibb Has Great Potential Ahead of Earnings
Ahead earnings, Bristol-Myers Squibb is a great value play. In fact, BMY stock is worth 30%-70% more than its current share price.
Undervalued Bristol-Myers Squibb Stock Is Worth 50% More
BMY stock looks cheap here. Bristol-Myers is a defensive value with an attractive yield, cheap valuation, and plenty of potential upside.
3 Big Stock Charts for Friday: Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline
Friday's big stock charts feature pharmaceutical-market names that recently posted terrific earnings data.
3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb
Tuesday's big stock charts feature health-care-sector names that may offer value and leadership.
5 Top Stock Trades for Wednesday: AMZN, DKS, AAL, BMY, UAL
Amazon, Dick's Sporting Goods, American Airlines, United Airlines and Bristol-Myers Squibb were our top stock trades for Wednesday.
Is Amarin Stock a Top Pick for 2020?
Amarin stock has been on fire in 2019, but the reaction to its latest news was discouraging. Is that a buying opportunity or a warning sign?
Thursday’s Vital Data: Bristol-Myers Squibb, Cronos and Canopy Growth
Options trading was hot in Bristol-Myers Squibb, Cronos and Canopy Growth stock on Tuesday. Here’s what the data suggests moving forward.
Stock Market Today: New Highs; Buy Micron, Nvidia?
Goldman Sachs analysts came out with three conviction buys on Monday. Here's what else happened in the stock market today.
4 Top Stock Trades for Monday: GS, BIG, BMY
Goldman Sachs, Bristol-Myers Squibb, Zoom Video and Big Lots were our top stock trades from Friday.
Thursday’s Vital Data: Bristol-Myers Squibb, Shopify and Walmart
Options trading was buzzing in Bristol-Myers Squibb, Shopify and Walmart stock on Wednesday. Here are the metrics that matter moving forward.
4 Top Stock Trades for Tuesday: ROKU, GOGO, BAC, BMY
Roku, Bristol-Myers Squibb, Bank of America and Gogo were our top stock trades for Tuesday. Here's a look at the charts.
10 Stocks Owned by the World’s Richest and Most Powerful
Billionaire-owned companies perform twice as well as others. Turns out the world's wealthiest and most powerful make for good investors.
Stock Market Today: The Deals Are Getting Done
Charles Schwab to purchase TD Ameritrade? Let's look at all of the M&A news making noise in the stock market today.
